Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus.

导出 OA

翻译打印收藏纠错

作者： Pengxiu,Dai ^[1] ; Guixiang,Qi ^[1] ; Haojie,Xu ^[1] ; Mingde,Zhu ^[1] ; Jiakai,Li ^[1] ; Yijing,Chen ^[1] ; Luwen,Zhang ^[1] ; Xinke,Zhang ^[1] ; Yihua,Zhang ^[2]

作者单位： Shaanxi Branch of National Stem Cell Engineering and Technology Centre, College of Veterinary Medicine, Northwest A&F University, Yangling, 712100, Shaanxi, China. ^[1] Shaanxi Branch of National Stem Cell Engineering and Technology Centre, College of Veterinary Medicine, Northwest A&F University, Yangling, 712100, Shaanxi, China. zyh19620207@163.com. ^[2] Baiopai (Tianjin) Biotechnology Co., LTD, Jinnan District, Tianjin, 300350, China. zyh19620207@163.com. ^[3]

关键词 Canine diabetes mellitus Cell transplantation therapy Immunogenicity Ra-βCs aMSCs

主题词脂肪组织(Adipose Tissue);动物(Animals);糖尿病, 1型(Diabetes Mellitus, Type 1);狗(Dogs);胰岛(Islets of Langerhans);胰岛移植(Islets of Langerhans Transplantation);间质干细胞(Mesenchymal Stem Cells)

DOI 10.1186/s13287-022-03020-w

PMID 35902971

发布时间 2022-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交